Cargando…

Predictive modeling of COPD exacerbation rates using baseline risk factors

BACKGROUND: Demographic and disease characteristics have been associated with the risk of chronic obstructive pulmonary disease (COPD) exacerbations. Using previously collected multinational clinical trial data, we developed models that use baseline risk factors to predict an individual’s rate of mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Dave, Hurst, John R., Martinez, Fernando J., Rabe, Klaus F., Bafadhel, Mona, Jenkins, Martin, Salazar, Domingo, Dorinsky, Paul, Darken, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340368/ https://www.ncbi.nlm.nih.gov/pubmed/35815359 http://dx.doi.org/10.1177/17534666221107314

Ejemplares similares

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
por: Bafadhel, Mona, et al.
Publicado: (2022)

Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial
por: Rabe, Klaus F., et al.
Publicado: (2021)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
por: Singh, Dave, et al.
Publicado: (2021)

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS
por: Martinez, Fernando J, et al.
Publicado: (2021)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Building toolkits for COPD exacerbations: lessons from the past and present
por: Sapey, Elizabeth, et al.
Publicado: (2019)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
por: Muro, Shigeo, et al.
Publicado: (2021)

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
por: Muro, Shigeo, et al.
Publicado: (2021)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Renaming COPD exacerbations: the UK respiratory nursing perspective
por: Mwasuku, Christine, et al.
Publicado: (2021)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
por: Camp, James, et al.
Publicado: (2018)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis
por: Bafadhel, Mona, et al.
Publicado: (2020)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
por: Beeh, Kai M, et al.
Publicado: (2013)

Effects of baseline symptom burden on treatment response in COPD
por: Martinez, Fernando J, et al.
Publicado: (2019)

Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol
por: Calverley, Peter MA, et al.
Publicado: (2012)

Exacerbation rate, health status and mortality in COPD – a review of potential interventions
por: Seemungal, Terence AR, et al.
Publicado: (2009)

Cardiovascular disease and COPD: dangerous liaisons?
por: Rabe, Klaus F., et al.
Publicado: (2018)

Predicting treatment outcomes following an exacerbation of airways disease
por: Halner, Andreas, et al.
Publicado: (2021)

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
por: Mackay, Alexander J., et al.
Publicado: (2020)

COPD Exacerbations: A Patient and Physician’s Perspective
por: Linnell, John, et al.
Publicado: (2019)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

Towards precision in defining COPD exacerbations
por: Jenkins, Christine R.
Publicado: (2021)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations
por: Barker, Bethan L., et al.
Publicado: (2015)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
por: Russell, REK, et al.
Publicado: (2019)

Pneumonia in exacerbations of COPD: what is the clinical significance?
por: Trethewey, Samuel P., et al.
Publicado: (2020)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease and exacerbations: Patient insights from the global Hidden Depths of COPD survey
por: Barnes, Neil, et al.
Publicado: (2013)

National clinical audit for hospitalised exacerbations of COPD
por: Hurst, John R., et al.
Publicado: (2020)

Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial
por: Rabe, Klaus F., et al.
Publicado: (2020)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Prediction models for exacerbations in patients with COPD
por: Guerra, Beniamino, et al.
Publicado: (2017)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
por: Haldar, Koirobi, et al.
Publicado: (2017)

High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis
por: Chakrabarti, Arindam, et al.
Publicado: (2021)

Chronic Obstructive Pulmonary Disease Exacerbations: Do All Roads Lead to Rome?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2022)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
por: Bafadhel, Mona, et al.
Publicado: (2015)

Monitoring of Physiological Parameters to Predict Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review
por: Al Rajeh, Ahmed M., et al.
Publicado: (2016)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qf45hrvgvppo79h08q55h4m3t3